VeriChip Shares Jump After H1N1 Patent License Win
Become a member: Subscribe
- Money & Markets
- Weekly Solari Reports
- Cognitive Liberty
- Young Builders
- Ask Catherine
- News Trends & Stories
- Equity Overview
- War For Bankocracy
- Digital Money, Digital Control
- State Leader Briefings
- Food
- Food for the Soul
- Future Science
- Health
- Metanoia
- Solutions
- Spiritual Science
- Wellness
- Building Weatlh
- Via Europa
Solari’s Building Wealth materials are organized to inspire and support your personal strategic and financial planning.

Missing Money
Articles and video discussions of the $21 Trillion dollars missing from the U.S. government
No posts
- LATEST
- TOP SECTIONS
- SERIES
- Money & Markets
- Weekly Solari Reports
- Ask Catherine
- News Trends & Stories
- Equity Overview
- Cognitive Liberty
- Young Builders
- Building Wealth
- The War for Bankocracy
- Digital Money, Digital Control
- State Leader Briefings
- Food
- Food for the Soul
- Future Science
- Health
- Metanoia
- Solutions
- Spiritual Science
- Wellness
- Via Europa
- BLOGS
- RESOURCES
- COMMUNITY
- My Account
- Log In
- Subscribe
- Search
- Shop
- Support
- Donate
- Log Out
VeriChip Shares Jump After H1N1 Patent License Win
Shares of VeriChip Corp (CHIP.O) tripled after the company said it had been granted an exclusive license to two patents, which will help it to develop implantable virus detection systems in humans.
The patents, held by VeriChip partner Receptors LLC, relate to biosensors that can detect the H1N1 and other viruses, and biological threats such as methicillin-resistant Staphylococcus aureus, VeriChip said in a statement.
The technology will combine with VeriChip’s implantable radio frequency identification devices to develop virus triage detection systems.
Continue reading VeriChip Shares Jump After H1N1 Patent License Win
Our mission is to help you live a free and inspired life. This includes building wealth in ways that build real wealth in the wider economy. We believe that personal and family wealth is a critical ingredient of both individual freedom and community, health and well-being.
Nothing on The Solari Report should be taken as individual investment, legal, or medical advice. Anyone seeking investment, legal, medical, or other professional advice for his or her personal situation is advised to seek out a qualified advisor or advisors and provide as much information as possible to the advisor in order that such advisor can take into account all relevant circumstances, objectives, and risks before rendering an opinion as to the appropriate strategy.
Be the first to know about new articles, series and events.












































































































